Phenylephrine Eye — Membership Pricing

Other medications in Ophthalmology

• Pilocarpine
• Prednisolone Acetate
• Ranibizumab
• Tafluprost
• Timolol
• Timolol Ophthalmic
• Travoprost
• Tropicamide

About Phenylephrine Eye

Phenylephrine eye drops are a common solution for various eye conditions, offering relief from redness and swelling. At TheDrugClub, we understand the importance of affordable access to essential medications. Learn how you can save on phenylephrine eye and many other prescriptions, making your eye care more manageable and budget-friendly.

Phenylephrine eye drops are a medication primarily used to relieve minor eye irritation and redness. It's often found in over-the-counter products, but prescription-strength formulations are also available, particularly for specific medical procedures or conditions. This medication is a vasoconstrictor, meaning it works by narrowing the small blood vessels in the eye, which in turn reduces redness. It can also act as a mydriatic, causing the pupil to dilate, which is why it's sometimes used by ophthalmologists during eye exams to get a better view of the retina.

What It Treats:

Phenylephrine eye is commonly used to alleviate symptoms of:

• Eye redness: From minor irritations, allergies, or fatigue.
• Minor eye swelling: Associated with irritation.
• Pupil dilation: Often a necessary step for comprehensive eye examinations or certain surgical procedures.

It's important to note that while phenylephrine can relieve symptoms, it doesn't treat the underlying cause of eye conditions. Always consult a healthcare professional for persistent or severe eye issues.

How It Works:

The active ingredient, phenylephrine, belongs to a class of drugs called alpha-adrenergic agonists. When applied to the eye, it stimulates alpha-receptors in the blood vessels, causing them to constrict. This constriction reduces the blood flow to the surface of the eye, thereby decreasing redness. For pupil dilation, it acts on the muscles that control pupil size, causing them to contract and widen the pupil.

Typical Costs:

The cost of phenylephrine eye can vary significantly based on whether it's an over-the-counter (OTC) product or a prescription-strength formulation, the brand, the dosage, and the pharmacy. OTC versions might range from $10 to $30 without insurance or discounts. Prescription-strength phenylephrine, especially for specific medical uses, can be more expensive, potentially ranging from $20 to

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Phenylephrine Eye is approved for (FDA label)

Phenylephrine Hydrochloride Ophthalmic Solution, USP 10%, is indicated to dilate the pupil. Phenylephrine Hydrochloride Ophthalmic Solution is an alpha-1 adrenergic receptor agonist indicated to dilate the pupil ( 1 )

Source: Read the full FDA label on DailyMed. Label effective date: July 30, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Phenylephrine Eye (FDA label)

Phenylephrine hydrochloride ophthalmic solution, USP 10% is a clear, colorless, to yellow colored sterile topical ophthalmic solution containing phenylephrine hydrochloride 10%.: each mL contains 100 mg of phenylephrine hydrochloride. Ophthalmic solution (sterile): ( 3 ) 100 mg of phenylephrine hydrochloride in one mL of solution (10%)

Source: FDA prescribing information (DailyMed). Set ID: 1767c4b7-36a0-4e64-9091-2af22161402f. SPL document ID: 1cc4ae4f-b3bb-4902-9725-1504f5f199ac. Label effective date: July 30, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Phenylephrine Eye (FDA label)

The following serious adverse reactions are described below and elsewhere in the labeling: Cardiovascular Effects [See Warnings and Precautions (5.2) ] Elevation in Blood Pressure [See Warnings and Precautions (5.3) ] The following adverse reactions have been identified following use of phenylephrine hydrochloride ophthalmic solution. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Source: FDA prescribing information (DailyMed). Set ID: 1767c4b7-36a0-4e64-9091-2af22161402f. SPL document ID: 1cc4ae4f-b3bb-4902-9725-1504f5f199ac. Label effective date: July 30, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Phenylephrine Eye (FDA label)

The 10% strength is contraindicated in: Patients with hypertension, or thyrotoxicosis ( 4.1 ) Pediatric patients less than 1 year of age due to increased risk of systemic toxicity ( 4.2 ) 4.1 Cardiac and Endocrine Disease Phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. Phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients. 4.2 Pediatric Patients Less Than 1 Year of Age Phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. Phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients [See Dosage and Administration (2.2) ].

Source: FDA prescribing information (DailyMed). Set ID: 1767c4b7-36a0-4e64-9091-2af22161402f. SPL document ID: 1cc4ae4f-b3bb-4902-9725-1504f5f199ac. Label effective date: July 30, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Phenylephrine Eye (FDA label)

Not for injection: Topical ophthalmic use only ( 5.1 ) Serious cardiovascular reactions with 10% strength: Reactions have included ventricular arrhythmias and some have been fatal. Monitor blood pressure in patients with cardiovascular disease ( 5.2 ) Significant elevations in blood pressure: Caution in pediatric patients less than 5 years of age, and in patients with cardiovascular disease or hyperthyroidism. In patients at high risk, monitor blood pressure post treatment ( 5.3 ) Rebound miosis: Reported one day after instillation ( 5.4 ) 5.1 Topical Ophthalmic Use Only Phenylephrine hydrochloride ophthalmic solution 10% is not indicated for injection. 5.2 Cardiovascular Reactions There have been reports of serious cardiovascular reactions, including ventricular arrhythmias and myocardial infarctions, in patients using phenylephrine 10%. These episodes, some fatal, have usually occurred in patients with pre-existing cardiovascular diseases.

Source: FDA prescribing information (DailyMed). Set ID: 1767c4b7-36a0-4e64-9091-2af22161402f. SPL document ID: 1cc4ae4f-b3bb-4902-9725-1504f5f199ac. Label effective date: July 30, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Phenylephrine Eye (FDA label)

Atropine-like drugs: May exaggerate the adrenergic pressor response ( 7.1 ) Potent inhalation anesthetic agents: May potentiate cardiovascular depressant effects ( 7.1 ) 7.1 Agents That May Exaggerate Pressor Responses Concomitant use of phenylephrine and atropine may enhance the pressor effects and induce tachycardia in some patients. Phenylephrine may potentiate the cardiovascular depressant effects of some inhalation anesthetic agents.

Source: FDA prescribing information (DailyMed). Set ID: 1767c4b7-36a0-4e64-9091-2af22161402f. SPL document ID: 1cc4ae4f-b3bb-4902-9725-1504f5f199ac. Label effective date: July 30, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.